Terms of Service

TrialTrack (trialtrack.co.uk) is a free, independent clinical trial discovery and information platform. We aggregate publicly available information about paid clinical trials in the UK from multiple research facilities and present it in one searchable interface.

TrialTrack is entirely independent and has no affiliation, partnership, or commercial relationship with any of the research clinics, pharmaceutical companies, contract research organisations, or study sponsors whose trials are listed on this platform, including but not limited to Parexel, Fortrea, Hammersmith Medicines Research, Trials4Us, and Quotient Sciences.

Listing a trial on TrialTrack does not imply endorsement of any clinic or study, and clinics do not pay to be listed.

Trial information on TrialTrack is scraped automatically from clinic websites and updated regularly. While we take reasonable steps to keep information current and accurate, we cannot guarantee that listings are complete, up to date, or error-free at all times.

Trial listings may be delayed, inaccurate, or may not reflect changes made by clinics after our last update. Trials marked as Active may have since closed, and trials marked Inactive may have reopened.

Nothing on TrialTrack constitutes medical advice, clinical guidance, or a recommendation to participate in any trial. TrialTrack does not assess your suitability for any trial and makes no claims about the safety, efficacy, or outcomes of any study listed on this platform.

You should always consult a qualified healthcare professional before making decisions about clinical trial participation.

You may use TrialTrack for personal, non-commercial purposes to discover and learn about clinical trial opportunities. You agree not to:

• Use automated tools to scrape, copy, or reproduce TrialTrack's content or data at scale
• Use the platform to misrepresent yourself to clinics or apply for trials fraudulently
• Interfere with or disrupt the operation of the website
• Use the service for any unlawful purpose

By subscribing to our newsletter, you consent to receiving periodic emails containing new trial listings and updates. You can unsubscribe at any time using the unsubscribe link in any email, or by contacting us at [email protected].

We will not use your email address for any purpose other than sending you the newsletter service you subscribed to. See our Privacy Policy for full details on how we handle your data.

We collect anonymised behavioural data about how visitors use our website, including filter usage, page time, trial link clicks, and scroll patterns. This data does not identify you personally.

This anonymised data may be used commercially, including sharing with or selling to third parties for purposes such as market research or healthcare analytics. For full details and your opt-out rights, see our Privacy Policy.

The TrialTrack name, logo, website design, and original content are owned by TrialTrack. Trial descriptions and details originate from the respective clinic websites and remain the property of those organisations.

You may not reproduce, republish, or commercially exploit TrialTrack's original content without our written permission.

To the fullest extent permitted by law, TrialTrack accepts no liability for:

• Any inaccuracy, omission, or outdated information in trial listings
• Any loss or harm arising from your use of information on this platform
• Any decisions you make regarding clinical trial participation
• The conduct, practices, or outcomes of any clinic or study listed on the platform
• Any interruption or unavailability of the website

Use of TrialTrack is entirely at your own risk.

These Terms of Service are governed by the laws of England and Wales. Any disputes arising from your use of TrialTrack will be subject to the exclusive jurisdiction of the courts of England and Wales.

We may update these Terms of Service from time to time. Changes will be published on this page with an updated effective date. Continued use of the platform after changes are posted constitutes your acceptance of the updated terms.

For any questions about these terms, contact us at [email protected].